Viewing data from:

STREPTOMYCIN SULFATE

ANDA

STREPTOMYCIN SULFATE | A064210 | XGEN PHARMACEUTICALS DJB INC

1 strength0 unique patents0 unique exclusivities

API Supply Chain1 active DMF4 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SICHUAN LONG MARCH PHARMACEUTICAL CO LTDSTREPTOMYCIN SULFATE

DMF 136431998

VETERANS ADMINISTRATIONInactiveSTREPTOMYCIN

DMF 161947

PFIZER INCInactiveSTREPTOMYCIN SULFATE

DMF 133761998

GLAXOInactiveSTREPTOMYCIN SULFATE

DMF 134011998

RHONE POULENC RORER PHARMACEUTICALS INCInactiveSTREPTOMYCIN SULFATE

DMF 134851998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 30, 1998	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 1GM BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Jun 30, 1998

No patent or exclusivity listings for this strength.